Tuesday, November 30th, 2021 at 11am EST Current changes in technology and the impact of the COVID pandemic has greatly accelerated the adoption of RBM methodology and AI/ML assisted risk analysis. How are these changing directly impacting your future clinical trials as the industry is reorienting itself around a new normal with regards to monitoring and insights provided by integrated data reviews.
Register free: https://www.appliedclinicaltrialsonline.com/act_w/RBM_future
Event overview:
Current changes in technology and the impact of the COVID pandemic has greatly accelerated the adoption of RBM methodology and AI/ML assisted risk analysis. How are these changing directly impacting your future clinical trials as the industry is reorienting itself around a new normal with regards to monitoring and insights provided by integrated data reviews. The webinar will cover:
Register now to hear the latest capabilities that are changing how clinical trials are being delivered with better, more timely patient insights enhancing patient safety and improving overall study quality.
3 Key take-aways
Register free: https://www.appliedclinicaltrialsonline.com/act_w/RBM_future